ATH
Click for more information
10.0% 0.5¢ alterity therapeutics limited

Pran up 70% on Nasdaq pre market, page-15

  1. greanleaf
    17 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    03/01/19
    10:32
    Post #: 37011152
    as memory serves it was only a couple of years ago that Prana was looking for a partner to help fund the further dog studies needed to get the planned phase 3 trial up and running for Huntingtons disease.  Professor Shoulson is still involved with the company and it would be interesting to know what he thinks about running a phase 3 trial on pbt2 considering that he was previously very keen on the idea
    PBT Price at posting: 4.9¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
-0.001(10.0%) 		Mkt cap ! $23.60M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $17.8K 3.6M

Buyers (Bids)

No. Vol. Price($)
60 72143502 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 37260658 25
View Market Depth
Last trade - 10.32am 27/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.